These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33707689)

  • 41. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis.
    Brandl C; Bucci L; Schett G; Zaiss MM
    Eur J Immunol; 2021 Apr; 51(4):798-810. PubMed ID: 33594693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions.
    Nicolas GR; Chang PV
    Trends Pharmacol Sci; 2019 Jun; 40(6):430-445. PubMed ID: 31079848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation.
    Zhang J; Zhu S; Ma N; Johnston LJ; Wu C; Ma X
    Med Res Rev; 2021 Mar; 41(2):1061-1088. PubMed ID: 33174230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis.
    Xu X; Wang M; Wang Z; Chen Q; Chen X; Xu Y; Dai M; Wu B; Li Y
    Front Immunol; 2022; 13():1007610. PubMed ID: 36275747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects.
    Landsiedel R; Hahn D; Ossig R; Ritz S; Sauer L; Buesen R; Rehm S; Wohlleben W; Groeters S; Strauss V; Sperber S; Wami H; Dobrindt U; Prior K; Harmsen D; van Ravenzwaay B; Schnekenburger J
    Part Fibre Toxicol; 2022 Mar; 19(1):21. PubMed ID: 35321750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bridging intestinal immunity and gut microbiota by metabolites.
    Wang G; Huang S; Wang Y; Cai S; Yu H; Liu H; Zeng X; Zhang G; Qiao S
    Cell Mol Life Sci; 2019 Oct; 76(20):3917-3937. PubMed ID: 31250035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens.
    Vogt SL; Peña-Díaz J; Finlay BB
    Anaerobe; 2015 Aug; 34():106-15. PubMed ID: 25958185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut Microbial Antigenic Mimicry in Autoimmunity.
    Garabatos N; Santamaria P
    Front Immunol; 2022; 13():873607. PubMed ID: 35572569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enriched metabolites that potentially promote age-associated diseases in subjects with an elderly-type gut microbiota.
    Yoshimoto S; Mitsuyama E; Yoshida K; Odamaki T; Xiao JZ
    Gut Microbes; 2021; 13(1):1-11. PubMed ID: 33430687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
    Dong LN; Wang M; Guo J; Wang JP
    Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host-microbiota interaction-mediated resistance to inflammatory bowel disease in pigs.
    Zhao X; Jiang L; Fang X; Guo Z; Wang X; Shi B; Meng Q
    Microbiome; 2022 Jul; 10(1):115. PubMed ID: 35907917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis.
    Dagar S; Singh J; Saini A; Kumar Y; Chhabra S; Minz RW; Rani L
    Front Endocrinol (Lausanne); 2022; 13():1044673. PubMed ID: 36699026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.
    Zhao T; Wei Y; Zhu Y; Xie Z; Hai Q; Li Z; Qin D
    Front Immunol; 2022; 13():1007165. PubMed ID: 36159786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Sartor RB; Wu GD
    Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbiota, in the Halfway between Nutrition and Lung Function.
    Espírito Santo C; Caseiro C; Martins MJ; Monteiro R; Brandão I
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity.
    Brown EM; Kenny DJ; Xavier RJ
    Annu Rev Immunol; 2019 Apr; 37():599-624. PubMed ID: 31026411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.
    Matijašić M; Meštrović T; Paljetak HČ; Perić M; Barešić A; Verbanac D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.